Abagovomab

DB16077Investigational

Abagovomab is under investigation in clinical trial NCT00418574 (Efficacy Multicentre Trial of Immunotherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients).

Mechanism: Pharmacologically active on Mucin-16
Curator reviewed
Code names: ACA-125 · MEN-2234

Resolves to

Compound

UNII3YK0326U7XCAS792921-10-9

Targets

Q8WXI7MUC16

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

420Drug interactionsStructured to mechanism, not free text

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Abagovomab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account